TD Waterhouse Canada »

Lineage Cell Therapeutics In shares owned by TD Waterhouse Canada

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by TD Waterhouse Canada from 13F filings

Historical chart of TD Waterhouse Canada investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by TD Waterhouse Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.6k 1.5k 1.71
2024-06-30 $1.6k 850 1.94

More positions owned by TD Waterhouse Canada

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Microsoft Corporation (MSFT)
Apple (AAPL)
Enbridge (ENB)
JPMorgan Chase & Co. (JPM)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Amazon (AMZN)
Fortis (FTS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for TD Waterhouse Canada

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In